- Report
- July 2024
- 150 Pages
Global
From €3468EUR$3,750USD£2,899GBP
- Report
- July 2024
- 100 Pages
Global
From €3468EUR$3,750USD£2,899GBP
- Report
- June 2024
- 200 Pages
Global
From €7353EUR$7,950USD£6,145GBP
- Report
- February 2024
- 30 Pages
Global
From €3006EUR$3,250USD£2,512GBP
- Report
- January 2024
- 189 Pages
Global
From €6937EUR$7,500USD£5,798GBP
- Report
- November 2023
- 30 Pages
Global
From €2543EUR$2,750USD£2,126GBP
- Report
- November 2023
- 30 Pages
Global
From €2543EUR$2,750USD£2,126GBP
- Report
- November 2023
- 30 Pages
Global
From €2543EUR$2,750USD£2,126GBP
- Report
- February 2023
- 107 Pages
Global
From €6937EUR$7,500USD£5,798GBP
- Report
- February 2023
- 50 Pages
Global
From €3653EUR$3,950USD£3,053GBP
- Report
- September 2026
- 180 Pages
From €4393EUR$4,750USD£3,672GBP
- Report
- August 2026
- 90 Pages
From €4393EUR$4,750USD£3,672GBP
- Report
- August 2026
- 70 Pages
Australia
From €4393EUR$4,750USD£3,672GBP
- Report
- May 2025
- 70 Pages
Japan
From €4393EUR$4,750USD£3,672GBP
- Report
- February 2024
- 70 Pages
United States
From €4393EUR$4,750USD£3,672GBP
- Report
- February 2024
- 70 Pages
Thailand
From €4393EUR$4,750USD£3,672GBP
- Report
- February 2024
- 70 Pages
Philippines
From €4393EUR$4,750USD£3,672GBP
- Report
- February 2024
- 70 Pages
Oman
From €4393EUR$4,750USD£3,672GBP
- Report
- February 2024
- 70 Pages
Iran
From €4393EUR$4,750USD£3,672GBP
- Report
- February 2024
- 112 Pages
Middle East, Africa
From €4393EUR$4,750USD£3,672GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more